RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cassava Sciences Stock

Cassava Sciences Net Income 2024

Cassava Sciences Net Income

-38.17 M USD

Ticker

SAVA

ISIN

US14817C1071

WKN

A2PGL8

In 2024, Cassava Sciences's profit amounted to -38.17 M USD, a -60.73% increase from the -97.22 M USD profit recorded in the previous year.

The Cassava Sciences Net Income history

YEARNET INCOME (undefined USD)
2028e-
2027e-91.52
2026e-58.73
2025e20.07
2024e-38.17
2023-97.22
2022-76.25
2021-32.39
2020-6.33
2019-4.63
2018-6.56
2017-11.91
2016-14.85
2015-14.15
2014-12.39
201331.54
2012-3.45
2011-2.61
2010-12.02
2009-3.47
200815.35
200720.31
20066.19
2005-30.67
2004-37.78

Cassava Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cassava Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cassava Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cassava Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cassava Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cassava Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cassava Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cassava Sciences’s growth potential.

Cassava Sciences Revenue, EBIT and net profit per share

DateCassava Sciences RevenueCassava Sciences EBITCassava Sciences Net Income
2028e73.85 M undefined-34.48 M undefined0 undefined
2027e6.53 M undefined-107.92 M undefined-91.52 M undefined
2026e0 undefined-121.99 M undefined-58.73 M undefined
2025e102 M undefined-20.66 M undefined20.07 M undefined
2024e0 undefined-90.22 M undefined-38.17 M undefined
20230 undefined-105.96 M undefined-97.22 M undefined
20220 undefined-80.02 M undefined-76.25 M undefined
20210 undefined-32.87 M undefined-32.39 M undefined
20200 undefined-6.8 M undefined-6.33 M undefined
20190 undefined-4.96 M undefined-4.63 M undefined
20180 undefined-6.66 M undefined-6.56 M undefined
20170 undefined-11.95 M undefined-11.91 M undefined
20160 undefined-14.96 M undefined-14.85 M undefined
20150 undefined-14.2 M undefined-14.15 M undefined
20140 undefined-12.43 M undefined-12.39 M undefined
201341.12 M undefined31.37 M undefined31.54 M undefined
201210.89 M undefined-3.9 M undefined-3.45 M undefined
201111.48 M undefined-3.51 M undefined-2.61 M undefined
201016.81 M undefined-13.7 M undefined-12.02 M undefined
200920.56 M undefined-6.75 M undefined-3.47 M undefined
200863.73 M undefined8.71 M undefined15.35 M undefined
200765.98 M undefined10.17 M undefined20.31 M undefined
200653.92 M undefined-550,000 undefined6.19 M undefined
20055.08 M undefined-32.72 M undefined-30.67 M undefined
20040 undefined-38.96 M undefined-37.78 M undefined

Cassava Sciences stock margins

The Cassava Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cassava Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cassava Sciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cassava Sciences's sales revenue. A higher gross margin percentage indicates that the Cassava Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cassava Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cassava Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cassava Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cassava Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cassava Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cassava Sciences Margin History

Cassava Sciences Gross marginCassava Sciences Profit marginCassava Sciences EBIT marginCassava Sciences Profit margin
2028e0 %-46.69 %0 %
2027e0 %-1,653.13 %-1,401.92 %
2026e0 %0 %0 %
2025e0 %-20.25 %19.67 %
2024e0 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %76.29 %76.7 %
20120 %-35.81 %-31.68 %
20110 %-30.57 %-22.74 %
20100 %-81.5 %-71.51 %
20090 %-32.83 %-16.88 %
20080 %13.67 %24.09 %
20070 %15.41 %30.78 %
20060 %-1.02 %11.48 %
20050 %-644.09 %-603.74 %
20040 %0 %0 %

Cassava Sciences Aktienanalyse

What does Cassava Sciences do?

Cassava Sciences Inc. is a biotechnology company founded in 1998. Its headquarters is in Austin, Texas. The company aims to research the inflammatory causes of neurodegenerative diseases, such as Alzheimer's, and develop new treatment options and medications. Cassava Sciences' business model is based on the development and commercialization of innovative therapies through research, clinical trials, and partnerships with other companies. The company focuses on developing treatment options for Alzheimer's disease. Cassava Sciences consists of various divisions that work closely together. One focus of the company is researching and developing new medications for the treatment of Alzheimer's. The company collaborates closely with scientists to develop new treatment options. Another important aspect of Cassava Sciences is conducting clinical trials to test the effectiveness and safety of the developed medications. The company collaborates with globally renowned research institutions. One of Cassava Sciences' products is the medication PTI-125, which was developed for the treatment of Alzheimer's. The medication aims to target the inflammatory causes of the disease and slow down its progression. PTI-125 is currently in Phase IIb of clinical testing and shows promising results. In recent years, Cassava Sciences has formed several partnerships with other companies to advance research and development of new treatment options. For example, the company collaborates with Pfizer and AbbVie. The history of Cassava Sciences is marked by intensive research activity and the goal of improving the quality of life for people with Alzheimer's disease. The company's research findings have been presented at scientific conferences and received significant media attention. In summary, Cassava Sciences is an innovative biotechnology company focused on researching and developing treatment options for Alzheimer's. In addition to developing new medications, the company also conducts clinical trials and collaborates with other companies to advance research. Cassava Sciences sees itself as a pioneer in the field of Alzheimer's therapy and aims to significantly improve the quality of life for people with this condition. Cassava Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Cassava Sciences's Profit Margins

The profit margins of Cassava Sciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Cassava Sciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Cassava Sciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Cassava Sciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Cassava Sciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Cassava Sciences stock

How much profit has Cassava Sciences made this year?

Cassava Sciences has made -38.17 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -60.73% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Cassava Sciences publish its earnings?

Cassava Sciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Cassava Sciences?

The profits of Cassava Sciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Cassava Sciences?

You can learn more about the earnings of Cassava Sciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Cassava Sciences pay?

Over the past 12 months, Cassava Sciences paid a dividend of 5.25 USD . This corresponds to a dividend yield of about 17.59 %. For the coming 12 months, Cassava Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cassava Sciences?

The current dividend yield of Cassava Sciences is 17.59 %.

When does Cassava Sciences pay dividends?

Cassava Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cassava Sciences?

Cassava Sciences paid dividends every year for the past 0 years.

What is the dividend of Cassava Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cassava Sciences located?

Cassava Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cassava Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cassava Sciences from 12/24/2012 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 12/13/2012.

When did Cassava Sciences pay the last dividend?

The last dividend was paid out on 12/24/2012.

What was the dividend of Cassava Sciences in the year 2023?

In the year 2023, Cassava Sciences distributed 0 USD as dividends.

In which currency does Cassava Sciences pay out the dividend?

The dividends of Cassava Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Cassava Sciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Cassava Sciences

Our stock analysis for Cassava Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cassava Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.